Document Detail

Mitochondrial Biogenesis: a Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases.
MedLine Citation:
PMID:  24606804     Owner:  NLM     Status:  Publisher    
In the developing and mature brain, mitochondria act as central hubs for distinct but interwined pathways, necessary for neural development, survival, activity, connectivity and plasticity. In neurons, mitochondria assume diverse functions, such as energy production in the form of ATP, calcium buffering and generation of reactive oxygen species. Mitochondrial dysfunction contributes to a range of neurodevelopmental and neurodegenerative diseases, making mitochondria a potential target for pharmacological-based therapies. Pathogenesis associated with these diseases is accompanied by an increase in mitochondrial mass, a quantitative increase to overcome a qualitative deficiency due to mutated mitochondrial proteins that are either nuclear- or mitochondrial-encoded. This compensatory biological response is maladaptive, as it fails to sufficiently augment the bioenergetically functional mitochondrial mass and correct for the ATP deficit. Since regulation of neuronal mitochondrial biogenesis has been scantily investigated, our current understanding on the network of transcriptional regulators, co-activators and signaling regulators mainly derives from other cellular systems. The purpose of this review is to present the current state of our knowledge and understanding of the transcriptional and signaling cascades controlling neuronal mitochondrial biogenesis and the various therapeutic approaches to enhance the functional mitochondrial mass in the context of neurodevelopmental disorders and adult-onset neurodegenerative diseases.
Martine Uittenbogaard; Anne Chiaramello
Related Documents :
22842144 - Dock7 interacts with tacc3 to regulate interkinetic nuclear migration and cortical neur...
24888524 - A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated...
23079624 - Activity-dependent, stress-responsive bdnf signaling and the quest for optimal brain he...
23879374 - Regulation and direction of umbilical cord blood mesenchymal stem cells to adopt neuron...
20164354 - Saccade suppression by electrical microstimulation in monkey caudate nucleus.
15889044 - Delayed treatment with monoclonal antibody in-1 1 week after stroke results in recovery...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-05
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Regulation And Quantification Of Cellular Mitochondrial Morphology And Content.
Next Document:  Mitochondria: Prospective Targets for Neuroprotection in Parkinson's Disease.